Treatment of advanced hepatocellular carcinoma with depot somatostatin analogues: a pilot prospective study based on somatostatin receptors tumors expression.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lanreotide; Octreotide
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms SS-HCC
- 17 Aug 2009 Biomarkers information updated
- 27 Jan 2009 Actual patient numbers (25) added as reported by ClinicalTrials.gov.
- 27 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.